<DOC>
	<DOCNO>NCT00398073</DOCNO>
	<brief_summary>RATIONALE : Vaccines make DNA may help body build effective immune response kill tumor cell . Giving vaccine different way may make strong immune response kill tumor cell . PURPOSE : This randomized clinical trial study two different way give vaccine therapy compare well work treat patient stage IIB , stage IIC , stage III , stage IV melanoma .</brief_summary>
	<brief_title>Vaccine Therapy Treating Patients With Stage IIB , Stage IIC , Stage III , Stage IV Melanoma</brief_title>
	<detailed_description>OBJECTIVES : Primary - Evaluate safety feasibility particle-mediated epidermal delivery ( PMED ) immunization comprise mouse gp100 plasmid DNA vaccine patient stage IIB , IIC , III , IV melanoma . - Compare immunologic response induce PMED v intramuscular jet injection method vaccination patient . Secondary - Observe patient measurable tumor evidence antitumor response generate vaccination . - Assess disease relapse patient treat vaccine . OUTLINE : This randomize , pilot study . Patients randomize 1 2 treatment arm . - Arm I : Patients receive mouse gp100 plasmid DNA vaccine particle-mediated epidermal delivery day 1 , 3 , 5 , 8 , 22 , 24 , 26 , 29 , 43 , 45 , 47 , 50 , 64 , 66 , 68 , 71 . - Arm II : Patients receive mouse gp100 plasmid DNA vaccine intramuscular jet injection day 1 , 3 , 5 , 8 , 22 , 24 , 26 , 29 , 43 , 45 , 47 , 50 , 64 , 66 , 68 , 71 . After completion study treatment , patient follow periodically 1 year .</detailed_description>
	<mesh_term>Melanoma</mesh_term>
	<mesh_term>Uveal Neoplasms</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm malignant melanoma Stage IIB , IIC , III , IV disease Patients free disease surgical resection must meet 1 follow criterion : Refused highdose interferon alfa Recurrence interferon alfa Patients stage IIB , IIC , III disease must already undergo initial standard therapy ( i.e. , surgery ) disease Choroidal ( uveal ) melanoma allow provide 1 follow criterion meet : Basal diameter &gt; 16 mm Basal height &gt; 8 mm Involvement ciliary body tumor HLAA*0201 positive Negative serum antidoublestranded DNA antibody screen No known brain metastasis PATIENT CHARACTERISTICS : Karnofsky performance status 80100 % Platelet count ≥ 100,000/mm^3 Absolute neutrophil count ≥ 1,500/mm^3 WBC ≥ 3,000/mm^3 Lactic dehydrogenase ≤ 2 time upper limit normal ( ULN ) Creatinine ≤ 2.0 mg/dL Bilirubin ≤ 2.5 time ULN Albumin ≥ 3.5 mg/dL Not pregnant nursing Negative pregnancy test Fertile patient must use effective contraception Weight ≥ 25 kg No preexisting choroidal eye disease No serious underlie medical condition could exacerbate study participation ( i.e. , active infection require antimicrobial drug active bleeding ) No allergy gold ( i.e. , gold jewelry ) No evidence condition propose site ( ) vaccine administration might interfere interpretation local skin reaction , include follow : Damaged skin Moles Scars Tattoos Marks No prior medical condition use medication ( e.g. , corticosteroid ) might make difficult patient complete full course treatment respond immunologically vaccines No history evidence ( within past 5 year ) physiciandiagnosed chronic recurrent inflammatory skin disease propose site vaccine administration , include follow : Psoriasis Eczema Atopic dermatitis Hypersensitivity No history keloid formation PRIOR CONCURRENT THERAPY : See Disease Characteristics At least 4 week since prior chemotherapy , immunotherapy , radiotherapy ( 6 week nitrosoureas ) recover No prior immunization class vaccine contain gp100 peptide No concurrent investigational agent No concurrent systemic therapy radiotherapy</criteria>
	<gender>All</gender>
	<minimum_age>1 Year</minimum_age>
	<maximum_age>120 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>stage II melanoma</keyword>
	<keyword>stage III melanoma</keyword>
	<keyword>stage IV melanoma</keyword>
	<keyword>recurrent melanoma</keyword>
	<keyword>ciliary body choroid melanoma , medium/large size</keyword>
	<keyword>ciliary body choroid melanoma , small size</keyword>
	<keyword>recurrent intraocular melanoma</keyword>
	<keyword>metastatic intraocular melanoma</keyword>
</DOC>